- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02779673
The Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level
May 19, 2016 updated by: Yonsei University
Investigation of the Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level in Korean Adult
The purpose of randomized, double-blind, placebo-controlled study was to determine whether yoghurt drink containing 2g plant stanols (3.4g as plant stanol esters) is effective in the control of blood cholesterol level in subjects with LDL-cholesterol level 130-159mg/dL.
Study Overview
Status
Completed
Conditions
Detailed Description
The objective of clinical trial was to evaluate the effect of yoghurt drink containing 2g plant stanols (3.4g as plant stanol esters) on blood cholesterol level.
A randomized, double-blinded, placebo-controlled study was conducted on subjects with LDL-cholesterol level 130-159mg/dL.
The subjects were randomly assigned to either a group ingesting yoghurt drink containing 2g plant stanols (3.4g as plant stanol esters) or a placebo group (yoghurt drink without plant stanols) for 4-week.
The investigators assessed blood cholesterol level.
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
• LDL-cholesterol level 130-159mg/dL (not taking cholesterol-lowering medications)
Exclusion Criteria:
- taking any medications (including anti-hypertensive, lipid lowering, anti-platelets, and anti-diabetic drugs)
- history of serious cardiovascular, pulmonary, gastrointestinal, hepatic, renal and/or haematological disease
- history or presence of cancer
- history of a psychiatric disorder and/or drug or alcohol abuse or dependency;
- having a known intolerance to gluten or lactose
- having a known allergy to any ingredient in the investigational product
- women who are pregnant or desire to become pregnant during the study period or within 3 months of giving birth or breast feeding or within 3 months of cessation of breast feeding
- having any other medical condition which, in the opinion of the investigator, could interfere with participation in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test group
Subjects randomized to the test group consumed yoghurt drink containing 3.4g plant stanol as ester for 1 per day for a period of 4 weeks.
|
|
Placebo Comparator: Placebo group
Subjects randomized to the placebo group consumed yoghurt drink without plant stanol as ester for 1 per day for a period of 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline LDL-cholesterol at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Change from baseline total cholesterol at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Change from baseline non-HDL-cholesterol at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline triglyceride at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Change from baseline HDL-cholesterol at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Change from baseline Apolipoprotein A1 at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Change from baseline Apolipoprotein B at 4-week
Time Frame: at baseline and 4-week follow-up
|
at baseline and 4-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
May 18, 2016
First Submitted That Met QC Criteria
May 18, 2016
First Posted (Estimate)
May 20, 2016
Study Record Updates
Last Update Posted (Estimate)
May 23, 2016
Last Update Submitted That Met QC Criteria
May 19, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- LF_cholesterol
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on LDL-cholesterol Level 130-159mg/dL
-
Universiteit AntwerpenCompletedCholesterol Level | HDL Level | LDL Level | TG LevelBelgium
-
Ramathibodi HospitalAstraZenecaUnknownSystemic Lupus Erythematosus | High LDL Cholesterol LevelThailand
-
Osaka UniversityMerck Sharp & Dohme LLCUnknownHyper-LDL-cholesterolemia | Low CETP Activity | CETP Deficiency | Hyperalphalipoproteinemia | High Level of Remnant CholesterolJapan
Clinical Trials on Yoghurt drink containing plant stanol as esters
-
Maastricht University Medical CenterRaisio Group; TKI Life Sciences and Health (LSH)RecruitingCardiovascular Diseases | Asthma, AllergicNetherlands
-
University of LimerickCompletedCardiovascular DiseasesIreland
-
Maastricht University Medical CenterCompleted
-
Gerencia de Atención Primaria, AlbaceteFundación para la Investigación Sanitaria en Castilla-La Mancha (FISCAM); Castilla-La...UnknownHypercholesterolemia
-
Raisio GroupCompletedDyslipidemias | Hypercholesterolemia | HyperlipidemiasTurkey
-
Maastricht University Medical CenterUnilever R&DCompleted
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone ResearchCompletedHypercholesterolemiaUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan